Liquid alternatives specialist Balter Capital Management
launched an all-capitalization long/short equity mutual fund in
partnership with Invenomic Capital Management. The Balter Invenomic
Fund (BIVIX) will have its operations and compliance managed out of
the Balter Liquid Alternatives unit, with Invenomic acting as
sub-adviser. The fund will utilize quantitative analysis on the
front end along with fundamental analysis on the back end to invest
in both large and small companies, predominately in the U.S.
Link To Article
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
